HDFC Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1896 Cr | ₹3933 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 31 Dec 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.14 | 1.94 |
| Manager | Dhruv Muchhal | Pradeep Kesavan |
| ISIN Code | INF179KC1HL7 | INF200K01446 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | 2.06% | 2.52% |
| 6 Month | 7.93% | 3.45% |
| 1 Year | 6.22% | 2.53% |
| 3 Year | - | 24.41% |
| 5 Year | - | 19.99% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | 0.61% | -0.66% |
| 1 Year | 7.49% | 2.03% |
| 3 Year | - | 20.08% |
| 5 Year | - | 19.02% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 27.59% | 15.65% |
| 3 Year | - | 17.81% |
| 5 Year | - | 12.99% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | - | 14.07% |
| Sharp | - | 1.18% |
| Beta | - | 0.84% |
| Alpha | - | 3.29% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Dhruv Muchhal | Pradeep Kesavan |
| Total AUM | ₹520687 Cr | ₹434274 Cr |
| Funds Managed | 40 | 43 |
| HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 7.7 | 13.04 |
| Mid Cap | 30.89 | 27.23 |
| Small Cap | 35.06 | 34.17 |
| Large Cap | 26.35 | 25.56 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.03 | 3.64 |
| Basic Materials | 2.31 | 5.69 |
| Healthcare | 96.66 | 90.67 |
Top Comparisons
Kotak Arbitrage Fund - Growth
3Y Returns7.2%
Mirae Asset Arbitrage Fund Regular Growth
3Y Returns6.88%
ICICI Prudential Corporate Bond Fund - Growth
3Y Returns7.92%
Sundaram Corporate Bond Fund Regular Plan- Growth
3Y Returns7.46%
ICICI Prudential Savings Fund - Growth
3Y Returns7.75%
DSP Low Duration Fund - Regular Plan - Growth
3Y Returns7.25%
BANDHAN MULTI CAP FUND - GROWTH - REGULAR PLAN
3Y Returns17.85%
Invesco India Multicap Fund - Growth Option
3Y Returns18.08%